Guntram Paul

Title: Guntram Paul: Innovator in Aviadenovirus Research

Introduction

Guntram Paul is a notable inventor based in Bedburg-Hau, Germany. He has made significant contributions to the field of virology, particularly in the study of infectious bursal disease virus and aviadenoviruses. With a total of 2 patents, his work has implications for both veterinary and medical science.

Latest Patents

One of Guntram Paul's latest patents is focused on an infectious bursal disease virus (IBDV) mutant. This mutant expresses virus neutralizing epitopes specific for both classic and variant IBDV strains. The invention provides a classic IBDV mutant that additionally comprises virus neutralizing epitopes 67, which are specific for variant-E IBDV. Another significant patent relates to a new aviadenovirus isolated from a pigeon. This aviadenovirus comprises group-I specific antigen and cannot be neutralized by antiserum against any of the FAV serotypes 1-12. The invention also includes an antibody or antiserum that is immunoreactive with a fiber of the new aviadenovirus, as well as a vaccine against PiAV related diseases.

Career Highlights

Throughout his career, Guntram Paul has worked with prominent companies such as Akzo Nobel N.V. and Intervet International B.V. His experience in these organizations has contributed to his expertise in virology and vaccine development.

Collaborations

Guntram has collaborated with notable colleagues, including Michael Bernhard Hess and Egbert Mundt. These partnerships have furthered his research and innovation in the field.

Conclusion

Guntram Paul is a distinguished inventor whose work in virology has led to important advancements in the understanding and treatment of viral diseases. His patents reflect a commitment to innovation and scientific progress.